| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |